References
- Kemp D T. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978; 64: 1386–91
- Gold T. Hearing, III: The physical basis of the action of the cochlea. Proc R Soc Lond Biol 1948; B135: 492–8
- Bonfils P, Dumont A, Marie P, Francois M, Narcy P. Evoked otoacoustic emissions in newborn hearing screening. Laryngoscope 1990; 100: 186–9
- Probst R. Otoacoustic emissions: an overview. Adv Otorhinolaryngol 1990; 44: 186–9
- Avan P, Bonfils P. Stimulus‐frequency and distortion‐product emissions: an overview of techniques and applications in physiopathology. Advances in otoacoustic emissions. Vol. 2. Recording techniques for otoacoustic emissions, R Thornton, F Grandori. Karger, Basel 1994, in press
- Kim D O., Molnar C E., Matthews J W. Cochlear mechanics: nonlinear behavior in two‐tone responses as reflected in cochlear‐nerve‐fiber responses and in ear‐canal sound pressure. J Acoust Soc Am 1980; 67: 1704–21
- Avan P, Bonfils P. Frequency specificity of human distortion product otoacoustic emissions. Audiology 1993; 32: 12–26
- Popelka G R., Osterhammel P A., Nielsen L H., Ras‐mussen A N. Growth of distortion‐product otoacoustic emissions with primary‐tone level in humans. Hear Res 1993; 71: 12–22
- Bonfils P, Avan P. Distortion‐product otoacoustic emissions. Values for clinical use. Arch Otolaryngol Head Neck Surg 1992; 118: 1069–76
- Bonfils P, Avan P, Londero A, Trotoux J, Narcy P. Objective low‐frequency audiometry by distortion‐product acoustic emissions. Arch Otolaryngol Head Neck Surg 1991; 117: 1167–71
- Brown A M., McDowell Forge A. Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear Res 1989; 42: 143–56